KEAP1 and cancer: Genetic alterations in KEAP1, NRF2, and CUL3 such as somatic mutations, copy number variations, and epigenetic changes are the major reasons for the gain-of-function and aberrant activation of NRF2-regulated pathways in human cancers and are often correlated with poor prognosis and survival [65, 66].